-
Efficacy and Safety of a Fixed Combination of Irbesartan/Hydrochlorothiazide in Chinese Patients with Moderate to Severe Hypertension
Author: Qi-Fang Huang, , Chang-Sheng Sheng, Yan Li, Gen-Shan Ma, Qiu-Yan Dai, Ji-Guang Wang
Journal: Drugs in research & development, 2013, Vol.13, 109-117, DOI:10.1007/s40268-013-0013-9
-
Bioequivalence and Pharmacokinetic Evaluation of Two Formulations of Risperidone 2 mg
Author: Yun Liu, Meng-qi Zhang, Jing-ying Jia, Yan-mei Liu, Gang-yi Liu, Shui-jun Li, Wei Wang, Li-ping Weng, Chen Yu
Journal: Drugs in research & development, 2013, Vol.13, 29-36, DOI:10.1007/s40268-012-0002-4
-
Efficacy and Safety of a Fixed Combination of Irbesartan/Hydrochlorothiazide in Chinese Patients with Moderate to Severe Hypertension
Author: Qi-Fang Huang, , Chang-Sheng Sheng, Yan Li, Gen-Shan Ma, Qiu-Yan Dai, Ji-Guang Wang
Journal: Drugs in research & development, 2013, Vol.13, 109-117, DOI:10.1007/s40268-013-0013-9
-
Pharmacokinetics of Cefozopran by Single and Multiple Intravenous Infusions in Healthy Chinese Volunteers
Author: G. L. Wu, J. Z. Shentu, H. L. Zhou, M. X. Zhu, X. J. Hu, J. Liu, L. H. Wu
Journal: Drugs in research & development, 2015, Vol.15, 63-70, DOI:10.1007/s40268-014-0075-3
-
A Multinational, Randomized, Open-label, Treat-to-Target Trial Comparing Insulin Degludec and Insulin Glargine in Insulin-Naïve Patients with Type 2 Diabetes Mellitus
Author: Changyu Pan, Jorge L. Gross, Wenying Yang, Xiaofeng Lv, Li Sun, Charlotte Thim Hansen, Hongfei Xu, Robert Wagner
Journal: Drugs in research & development, 2016, Vol.16, 239-249, DOI:10.1007/s40268-016-0134-z
